Skip to main content

Table 6 Markers for T, NK and B-cells and Neutrophils.

From: Macrophage invasion contributes to degeneration of stria vascularis in Pendred syndrome mouse model

    Slc26a4 +/+ Slc26a4 -/-   
No. Gene Description Intensity P Intensity P Fold Direction
1 Tcra T-cell receptor, alpha 214 0/9 190 0/9   
2 Tcrb-V13 T-cell receptor, beta V13 136 4/36 109 4/36   
3 Tcrb-J T-cell receptor, beta V13 71 2/15 50 1/15   
4 Tcrg T-cell receptor, gamma V4 54 0/15 43 0/15   
5 Cd3d Cd3 antigen 10 0/3 8 0/3   
6 Cd3e Cd3 antigen 139 0/6 74 0/6   
7 Cd3g Cd3 antigen 43 0/3 28 0/3   
8 Cd3z Cd3 antigen 182 4/24 139 3/24   
9 Cd4 Cd4 antigen 20 0/6 149 0/6   
10 Cd8a Cd8 antigen 144 4/15 143 4/15   
11 Cd8b Cd8 antigen 1,313 3/6 1,343 3/6   
12 Ncam1 Cd56 562 8/21 654 12/21 1.16  
13 Fcgr3 IgG receptor, low aff, Cd16 162 2/3 401 3/3 2.48 up
14 Sdc1 Syndecan 1 (Cd138) 77 3/12 72 3/12   
15 Cd19 Cd19 antigen 15 0/3 13 0/3   
16 Mpo Myeloperoxidase 159 0/3 73 0/3   
17 Defb1 Beta-defensin 1 66 1/6 72 2/6   
18 Defb2 Beta-defensin 2 23 0/3 14 0/3   
19 Defb3 Beta-defensin 3 31 0/3 70 0/3   
20 Defb4 Beta-defensin 4 85 0/3 63 0/3   
21 Camp Cathelicidin 11 0/3 10 0/3   
  1. Genes that can serve as markers for T-cells (1–11), NK-cells (12–13), B-cells (14–15) and neutrophils (16–21) are listed. For parameters 'P', 'Fold' and 'Direction', see the Gene array section in Methods. Fold changes are given when a gene was called Present (P) in Slc26a4 +/- or Slc26a4 -/- samples in at least half of the available probes. The direction of the fold change is only given when it exceeded 1.30. Fold changes lower than 1.30 were not considered significant.